Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Navidea Biopharmaceuticals (CE) (NAVB)

Navidea Biopharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:NAVB
DateTimeSourceHeadlineSymbolCompany
06/02/202400:53Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
01/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
26/01/202422:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
16/01/202418:53Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
20/11/202323:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
20/11/202323:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
13/11/202319:58Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:NAVBNavidea Biopharmaceuticals Inc (CE)
16/05/201414:47Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
18/02/201414:18Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
10/12/201314:33Dow Jones NewsU.S. Hot Stocks Futures: Hot Stocks to WatchAMEX:NAVBNavidea Biopharmaceuticals Inc.
24/04/201314:36Dow Jones NewsNavidea Sells More Shares to J.P. Morgan's Asset Management Unit and Another Institutional InvestorAMEX:NAVBNavidea Biopharmaceuticals Inc.
 Showing the most relevant articles for your search:USOTC:NAVB